“If the drug proves effective it could give patients a way to manage or lessen their symptoms even if a cure remains out of reach,” said Howard Feldman, M.D., renowned neurologist and director of the Alzheimer’s Disease Cooperative Study (ADCS).
“If the drug proves effective it could give patients a way to manage or lessen their symptoms even if a cure remains out of reach,” said Howard Feldman, M.D., renowned neurologist and director of the Alzheimer’s Disease Cooperative Study (ADCS).